Shuangcheng Pharmaceutical announced that Deputy General Manager Yao Zhong's plan to reduce holdings has been completed. On August 4, 2026, it reduced its holdings by 40,500 shares through centralized bidding, accounting for 0.01% of the total share capital, and reduced its holdings at an average price of 9.65 yuan/share. After this reduction in holdings, Yao Zhong's shareholding fell to 121,500 shares, accounting for 0.03% of the total share capital. The reduction in shareholding stems from the unlocked portion of the restricted shares granted by the company's 2021 incentive plan. This reduction in holdings will not result in a change in the company's control, nor is it illegal.

Shuangcheng Pharmaceutical announced that Deputy General Manager Yao Zhong's plan to reduce holdings has been completed. On August 4, 2026, it reduced its holdings by 40,500 shares through centralized bidding, accounting for 0.01% of the total share capital, and reduced its holdings at an average price of 9.65 yuan/share. After this reduction in holdings, Yao Zhong's shareholding fell to 121,500 shares, accounting for 0.03% of the total share capital. The reduction in shareholding stems from the unlocked portion of the restricted shares granted by the company's 2021 incentive plan. This reduction in holdings will not result in a change in the company's control, nor is it illegal.